Den europeiske union -
ungarsk -
EMA (European Medicines Agency)
kapruvia
vifor fresenius medical care renal pharma france - difelikefalin - pruritus - minden más terápiás készítmény - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.
Den europeiske union -
kroatisk -
EMA (European Medicines Agency)
kapruvia
vifor fresenius medical care renal pharma france - difelikefalin - pruritus - svi ostali terapeutski proizvodi - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.
Den europeiske union -
nederlandsk -
EMA (European Medicines Agency)
kapruvia
vifor fresenius medical care renal pharma france - difelikefalin - pruritus - alle andere therapeutische producten - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.
Den europeiske union -
litauisk -
EMA (European Medicines Agency)
kapruvia
vifor fresenius medical care renal pharma france - difelikefalin - pruritus - visi kiti gydomieji produktai - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.
Sveits -
fransk -
Swissmedic (Swiss Agency for Therapeutic Products)
solcoseryl 212.5 mg/5 ml i.v. solution injectable
meda pharmaceuticals switzerland gmbh - dialysatum deproteinatum du sang des veaux à sec - solution injectable - dialysatum deproteinatum sanguinis vituli siccum 212.5 mg, e 218, propylis parahydroxybenzoas, e 214, acidum parahydroxybenzoicum, aqua ad iniectabile q.s., ad solutionem pro 5 ml. - l'insuffisance veineuse chronique avec therapieresistentem les ulcères de jambe; artériopathie oblitérante des membres inférieurs (aomi) stade iii/iv - biotechnologika
Sveits -
fransk -
Swissmedic (Swiss Agency for Therapeutic Products)
solcoseryl 85 mg/2 ml i.v. solution injectable
meda pharmaceuticals switzerland gmbh - dialysatum deproteinatum du sang des veaux à sec - solution injectable - dialysatum deproteinatum sanguinis vituli siccum 85 mg, e 218, propylis parahydroxybenzoas, e 214, acidum parahydroxybenzoicum, aqua ad iniectabile q.s., ad solutionem pro 2 ml. - l'insuffisance veineuse chronique avec therapieresistentem les ulcères de jambe; artériopathie oblitérante des membres inférieurs (aomi) stade iii/iv - biotechnologika
Belgia -
fransk -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
legalon-sil 350 mg sol. inj. (pdr.) i.v. flac.
viatris healthcare sa-nv - succinate de dihydrogène de silibinine disodique 528,5 mg - eq. silibinine 350 mg - poudre pour solution injectable - 350 mg - succinate de dihydrogène de silibinine disodique 528.5 mg - other therapeutic products
Spania -
spansk -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
extracto de echinacea natysal 100 mg comprimidos
natysal s.a. - echinacea angustifolia exto seco - comprimido - 100 mg - echinacea angustifolia exto seco 100 mg - otros productos terapéuticos
Spania -
spansk -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
salviamed comprimidos
bioforce espana a vogel s.a. - salvia officinalis - comprimido - 51 mg - salvia officinalis 51 mg - otros productos terapéuticos
Romania -
rumensk -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
oscillococcinum
laboratoires boiron - franta - homeopate - gran. homeopate - alte preparate terapeutice alte preparate terapeutice